NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE

NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE was reported 62 times

NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS 1 0.0154
1 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
2 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
3 MUCOSAL DISORDER 1 0.0010
4 HAEMORRHAGE URINARY TRACT 1 0.0004
5 PROSTATE CANCER METASTATIC 1 0.0003
6 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
7 DROOLING 2 0.0003
8 RECURRENT CANCER 1 0.0002
9 PERIPHERAL VENOUS DISEASE 1 0.0002
10 KETOACIDOSIS 1 0.0001
11 HAEMATOTOXICITY 1 0.0001
12 HOSPICE CARE 1 0.0001
13 FULL BLOOD COUNT ABNORMAL 1 0.0001
14 PRODUCT PRESCRIBING ISSUE 2 0.0001
15 SHOCK 2 0.0001
16 ELECTROLYTE IMBALANCE 1 0.0001
17 BEDRIDDEN 1 0.0001
18 HUNGER 1 0.0001
19 DEVICE OCCLUSION 1 0.0001
20 CARDIOMYOPATHY 1 0.0001
21 PANCYTOPENIA 3 0.0001
22 BLOOD SODIUM DECREASED 1 0.0001
23 KIDNEY INFECTION 1 0.0001
24 BONE MARROW FAILURE 1 0.0000
25 ORAL PAIN 1 0.0000
26 PRODUCT PRESCRIBING ERROR 1 0.0000
27 LOCALISED INFECTION 1 0.0000
28 AGEUSIA 1 0.0000
29 PSYCHOTIC DISORDER 1 0.0000
30 NEOPLASM PROGRESSION 1 0.0000
31 ADVERSE EVENT 2 0.0000
32 HYPOKALAEMIA 1 0.0000
33 BLOOD PRESSURE INCREASED 3 0.0000
34 HAEMOGLOBIN DECREASED 2 0.0000
35 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
36 PLATELET COUNT DECREASED 2 0.0000
37 CONSTIPATION 4 0.0000
38 THROMBOCYTOPENIA 2 0.0000
39 HYPONATRAEMIA 1 0.0000
40 DECREASED APPETITE 4 0.0000
41 DISEASE PROGRESSION 2 0.0000
42 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
43 NEUTROPENIA 2 0.0000
44 ABDOMINAL PAIN UPPER 3 0.0000
45 INFECTION 2 0.0000
46 AGITATION 1 0.0000
47 HOT FLUSH 1 0.0000
48 DIABETES MELLITUS 1 0.0000
49 HOSPITALISATION 2 0.0000
50 PERIPHERAL SWELLING 2 0.0000
51 CARDIAC FAILURE 1 0.0000
52 CARDIAC FAILURE CONGESTIVE 1 0.0000
53 PROSTATE CANCER 1 0.0000
54 THROMBOSIS 1 0.0000
55 DRY MOUTH 1 0.0000
56 CARDIAC ARREST 1 0.0000
57 RENAL IMPAIRMENT 1 0.0000
58 ADVERSE DRUG REACTION 1 0.0000
59 PULMONARY EMBOLISM 1 0.0000
60 DYSPEPSIA 1 0.0000
61 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
62 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
63 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
64 VISION BLURRED 1 0.0000
65 OFF LABEL USE 6 0.0000
66 MALAISE 3 0.0000
67 DRUG INTERACTION 1 0.0000
68 DIZZINESS 3 0.0000
69 CEREBROVASCULAR ACCIDENT 1 0.0000
70 MYALGIA 1 0.0000
71 MYOCARDIAL INFARCTION 1 0.0000
72 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
73 ANAEMIA 1 0.0000
74 FATIGUE 4 0.0000
75 NAUSEA 4 0.0000
76 WEIGHT INCREASED 1 0.0000
77 DEPRESSION 1 0.0000
78 INCORRECT DOSE ADMINISTERED 1 0.0000
79 FEELING ABNORMAL 1 0.0000
80 WEIGHT DECREASED 1 0.0000
81 COUGH 1 0.0000
82 DEATH 3 0.0000
83 DIARRHOEA 2 0.0000
84 ASTHENIA 1 0.0000
85 ARTHRALGIA 1 0.0000
86 DRUG INEFFECTIVE 3 0.0000
87 VOMITING 1 0.0000